4 | SEC Filings Hub

Filing metadata

Accession number: 0001193125-26-104384
Form type: Form 4
Filer: BridgeBio Oncology Therapeutics, Inc.
CIK: CIK 1869105
Filed: Mar 12, 2026
Reporting period: Mar 10, 2026
Description: Insider transaction

Documents

0001193125-26-104384-index.htm

Complete submission

0001193125-26-104384.txt

directory listing

Filed by

BridgeBio Oncology Therapeutics, Inc.